Alphamab Oncology (9966.HK)

HKD 7.85

(21.52%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.13 Billion 2.11 Billion 2.7 Billion 2.63 Billion 2.85 Billion 826.89 Million
Total Current Assets 1.55 Billion 1.49 Billion 2.11 Billion 2.19 Billion 2.44 Billion 656.1 Million
Cash And Short Term Investments 1.4 Billion 1.35 Billion 1.98 Billion 2.06 Billion 2.38 Billion 633.71 Million
Cash and Cash Equivalents 1.08 Billion 1.06 Billion 803.3 Million 185.32 Million 1.86 Billion 633.71 Million
Short Term Investments 321.24 Million 247.85 Million 1.12 Billion 1.83 Billion 514.56 Million -
Net Receivables 7.13 Million 15.49 Million 7.6 Million -43.52 Million -11.67 Million 1.00
Inventory 78.74 Million 64.63 Million 57.9 Million 44.32 Million 25.91 Million 7.06 Million
Other Current Assets 65.41 Million 97.35 Million 119.56 Million 134.18 Million 47.79 Million 15.32 Million
Total Non-Current Assets 578.58 Million 619.74 Million 530.52 Million 393.02 Million 410.11 Million 170.79 Million
Net PPE 556.84 Million 619.74 Million 530.52 Million 393.02 Million 355.95 Million 135.09 Million
Good Will And Intangible Assets 20.69 Million 21.18 Million 21.68 Million 22.17 Million 22.66 Million 24.73 Million
Good Will - - - - - -
Intangible Assets 20.69 Million 21.18 Million 21.68 Million 22.17 Million 22.66 Million 24.73 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 1.05 Million -21.18 Million -21.68 Million -22.17 Million 31.49 Million 10.96 Million
Other Assets - 3.25 Million 58.01 Million 47.27 Million - -
Total Liabilities 465 Million 559.85 Million 834.8 Million 366.43 Million 428.65 Million 1.09 Billion
Total Current Liabilities 266.83 Million 384.91 Million 637.26 Million 329.53 Million 200.53 Million 82.8 Million
Account Payables 27.16 Million 12.12 Million 28.48 Million 5.27 Million 6.85 Million 766 Thousand
Tax Payables - - - - - -
Short Term Debt 80.49 Million 190.11 Million 463.81 Million 198.14 Million 41.83 Million 10.5 Million
Deferred Revenue -1.11 Million -190.11 Million -463.81 Million -198.14 Million - -
Other Current Liabilities 160.29 Million 372.78 Million 608.77 Million 324.25 Million 151.84 Million 71.53 Million
Total Non Current Liabilities 198.16 Million 150 Million 153.82 Million 21.35 Million 228.12 Million 1.01 Billion
Long-Term Debt 176.58 Million 150 Million 153.82 Million 21.35 Million 211.34 Million 100.51 Million
Deferred Revenue Non Current 21.58 Million 19.66 Million 24.08 Million 12.24 Million 16.78 Million 10 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 21.58 Million -150 Million -153.82 Million -21.35 Million -201.25 Million 999.85 Million
Other Liabilities - 24.94 Million 43.71 Million 15.55 Million - -
Total Equity 1.67 Billion 1.55 Billion 1.87 Billion 2.27 Billion 2.42 Billion -267.02 Million
Stock Holders Equity 1.67 Billion 1.55 Billion 1.87 Billion 2.27 Billion 2.42 Billion -267.02 Million
Common Stock 13 Thousand 13 Thousand 13 Thousand 13 Thousand 12 Thousand 7000.00
Retained Earnings -2.34 Billion -2.13 Billion -1.8 Billion -1.39 Billion -966.45 Million -147.37 Million
Accumulated other comprehensive income 1.67 Billion -35.85 Million -39.84 Million -45.45 Million -42.04 Million -8.23 Million
Common Stock Equity 1.67 Billion 1.55 Billion 1.87 Billion 2.27 Billion 2.42 Billion -267.02 Million
Capital Lease Obligation 7.08 Million 20.39 Million 33.45 Million 13.45 Million 23.17 Million 11.02 Million
Total Investments 321.24 Million 247.85 Million 1.12 Billion 1.83 Billion 514.56 Million -
Total Debt 257.08 Million 345.39 Million 637.27 Million 222.8 Million 253.17 Million 111.02 Million
Net Debt -828.9 Million -723.79 Million -166.03 Million 37.48 Million -1.61 Billion -522.69 Million

Balance Sheet Charts